Reneuron Group (OTC) (GB:RENE) has released an update.
ReNeuron Group plc, a prominent UK-based biotech company specializing in stem cell derived exosome technologies, has announced the resignation of John Hawkins, its Chief Financial Officer, effective from 7 May 2024. Hawkins will continue to assist the company during its administration process following his departure. The company’s Executive Chairman expressed gratitude for Hawkins’s contributions and extended best wishes for his future endeavors.
For further insights into GB:RENE stock, check out TipRanks’ Stock Analysis page.
